These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8474374)

  • 1. The rational use of the HIV antibody test.
    Dwyer JM; Stewart GJ; McDonald P
    Med J Aust; 1993 Mar; 158(5):327-8. PubMed ID: 8474374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
    Kumar M; Birch S; Maturana A; Gafni A
    Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of voluntary prenatal and routine newborn HIV screening.
    AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279876
    [No Abstract]   [Full Text] [Related]  

  • 4. Education in HIV risk screening, counseling, testing, and referral: survey of U.S. dental schools.
    Patton LL; Santos VA; McKaig RG; Shugars DC; Strauss RP
    J Dent Educ; 2002 Oct; 66(10):1169-77. PubMed ID: 12449212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of HIV screening in acute care settings.
    Owens DK; Nease RF; Harris RA
    Arch Intern Med; 1996 Feb; 156(4):394-404. PubMed ID: 8607724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
    Rivera-Alsina ME; Rivera CC; Rollene N; Kirby RS; Ayres A; McNamara M
    J Reprod Med; 2001 Mar; 46(3):243-8. PubMed ID: 11304866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compulsory HIV tests.
    Dunn RW
    CMAJ; 1999 May; 160(9):1286-7. PubMed ID: 10333827
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of screening for HIV.
    Taiwo BO
    N Engl J Med; 2005 May; 352(20):2137-9; author reply 2137-9. PubMed ID: 15901873
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
    van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
    Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal HIV prevention practices in a low seroprevalence state.
    McKinney MM; McSpirit S; Pomeroy C
    AIDS Educ Prev; 2000 Jun; 12(3):252-62. PubMed ID: 10926128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who should be screened for HIV infection? A cost-effectiveness analysis.
    McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
    Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine screening for HIV infection in booked antenatal women: how justified in developing countries?
    Ibekwe PC; Ikeme AC
    Afr J Reprod Health; 2001 Aug; 5(2):7-9. PubMed ID: 12471908
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmaco-economic evaluation of mandatory HIV-screening in pregnancy; a cost-efficacy analysis in Amsterdam].
    Postma MJ; van den Hoek JA; Beck EJ; Heeg B; Jager JC; Coutinho RA
    Ned Tijdschr Geneeskd; 2000 Apr; 144(16):749-54. PubMed ID: 10812443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid diagnostic testing for HIV. Clinical implications.
    Paul SM; Grimes-Dennis J; Burr CK; DiFerdinando GT
    N J Med; 2002 Sep; 99(9):20-4, quiz 24-6. PubMed ID: 12244703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine prenatal screening for HIV in a low-prevalence setting.
    Patrick DM; Money DM; Forbes J; Dobson SR; Rekart ML; Cook DA; Middleton PJ; Burdge DR
    CMAJ; 1998 Oct; 159(8):942-7. PubMed ID: 9834719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine screening for HIV infection--timely and cost-effective.
    Bozzette SA
    N Engl J Med; 2005 Feb; 352(6):620-1. PubMed ID: 15703428
    [No Abstract]   [Full Text] [Related]  

  • 17. Access to prenatal HIV testing.
    Remis RS; Patrick DM
    CMAJ; 1998 Jun; 158(11):1469-70. PubMed ID: 9629111
    [No Abstract]   [Full Text] [Related]  

  • 18. [Attitudes to counseling related to HIV infection screening in Bobo-Dioulasso, Burkina Faso].
    Cartoux M; Rouamba O; Meda N; Dabis F; Durand G; Salamon R
    Sante; 1996; 6(1):7-10. PubMed ID: 8612016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
    Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
    Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia.
    Graves N; Walker DG; McDonald AM; Kaldor JM; Ziegler JB
    J Infect Dis; 2004 Jul; 190(1):166-74. PubMed ID: 15195257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.